<DOC>
	<DOCNO>NCT01787136</DOCNO>
	<brief_summary>Dextromethorphan add methylphenidate patient attention deficit hyperactivity disorder</brief_summary>
	<brief_title>Dextromethorphan Added Patients With ADHD</brief_title>
	<detailed_description>Background : The disruptive symptom ADHD cause academic , interpersonal function impairment affect 5 % child . Dysregulation immunological function report either patient ADHD often comorbid neuropsychiatric disorder . Our study design investigate novel agent , dextromethorphan , antiinflammation neuroprotection way reduce ADHD symptom concurrent condition like tic , autistic feature . Methods : In first year , correlate cytokine level ADHD severity ( N=30 ) level proinflammatory cytokine measure cytokine protein array . The level cytokine correlate severity symptom . In second year , . patient ADHD randomly divide two group treat dextromethorphan added methylphenidate ( MPH ) ( N=30 ) MPH ( N=30 ) 8 week . The difference presence good responder two group analyze . In addition , investigate correlation reduction cytokine improvement severity ADHD .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Dextromethorphan</mesh_term>
	<criteria>Patients age 6 25 ADHD symptom recruit . They screen ADHD symptom SNAP 4th version . They refer psychiatrist make final diagnosis ADHD American Diagnostic Statistical Manual 4th version ( DSMIV ) . Patients willing participate study detailed explanation . Patients could follow investigator 's instruction Patients severe neurological mental illness like epileptic disorder , history stroke , schizophrenia , bipolar disorder , mental retardation uncontrolled suicide risk . Patients severe medical illness surgical condition like uncontrolled abnormal thyroid function , history heart attack , uncontrolled hypertension . Patients take antidepressant , psychotropic medicine within two month prior evaluation enter study . Patients allergic methylphenidate dextromethorphan . Patients autoimmune disorder Patients asthma severe infection disorder currently previous two month avoid influence level cytokine .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>